Clinical Trial Detail

NCT ID NCT01885689
Title Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia or Acute Leukemia in Remission
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors City of Hope Medical Center
Indications

bone marrow cancer

acute lymphoblastic leukemia

acute myeloid leukemia

Therapies

Clofarabine + Melphalan

Age Groups: adult

No variant requirements are available.